carlisle medical
Refill Requests shipment tracking contact carlisle medical
Knowledge Center
Industrial related news
FDA Approval for ZORVOLEX™
Released: 10/18/2013
By: Carl Richie, Pharmacy Manager

October 18, 2013 – Iroko Pharmaceuticals, LLC, announced that the FDA had approved ZORVOLEX™ (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the treatment of mild to moderate acute pain in adults. ZORVOLEX™ was approved at dosage strengths that are 20 percent lower than currently available diclofenac products.

The approval of ZORVOLEX™ is important news for patients and for physicians who need new options for pain relief.


<<Back
 
Company News
Generic Releases
Industry Related News
Industry Related Links
Newsletter Subscription
Newsletter Login
 
 
 
 
 
© Copyright 2018 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer